| 000 | 01596 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517132628.0 | ||
| 264 | 0 | _c20170801 | |
| 008 | 201708s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2016.69.5197 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJackson, Richard | |
| 245 | 0 | 0 |
_aImpact of Viral Status on Survival in Patients Receiving Sorafenib for Advanced Hepatocellular Cancer: A Meta-Analysis of Randomized Phase III Trials. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _cFeb 2017 |
||
| 300 |
_a622-628 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials, Phase III as Topic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPhenylurea Compounds _xtherapeutic use |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aPsarelli, Eftychia-Eirini | |
| 700 | 1 | _aBerhane, Sarah | |
| 700 | 1 | _aKhan, Harun | |
| 700 | 1 | _aJohnson, Philip | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 35 _gno. 6 _gp. 622-628 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2016.69.5197 _zAvailable from publisher's website |
| 999 |
_c26748900 _d26748900 |
||